Zacks.com on MSN5d
GSK Q3 Earnings Top, Stock Down on Lowered '24 View for Vaccine SalesGSK plc GSK reported third-quarter 2024 core earnings of $1.27 per American depositary share (ADS), which beat the Zacks Consensus Estimate of $1.16. Core earnings declined 1% year over year on a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback